Brainshake is now Nightingale Health
After three years of fast growing business in the medical research market, Brainshake changes its name into Nightingale Health. This coincides directly with the move in 2017 to clinical testing in Europe.
Nightingale, led by CEO Teemu Suna, aims to solve the world’s biggest health problem with its unique, proprietary and powerful blood testing re-invention. The technology has been proven to advance research in chronic diseases such as heart disease and diabetes, and is supported by over 100 peer-reviewed biomedical publications.


Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain
United Kingdom